China outreach with Pharmacore Labs


We are pleased to announce that we have formed a collaborative agreement with PharmaCore Labs (PCL, a leading ion channel-focused CRO in China). PCL will be providing us with dedicated business development personnel in China, as well as a staging facility for compound transshipment to the US and Europe.

This agreement will allow us to better serve our customers in China and allow more companies and universities in China to access our high-quality drug discovery services. PCL will be able to directly provide answers to our Chinese clients regarding:

  1. Our services and products
  2. Shipping compounds to the US and Europe
  3. IND filing paperwork
  4. Paying for services with Chinese currency


Please read the press release here or here for the Chinese version.